Trials / Unknown
UnknownNCT01754961
Effects of Vitamin D on Inflammation in Liver Disease
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Veterans Medical Research Foundation · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Chronic liver diseases are associated with inflammation. The investigators postulate that Vitamin D may modulate inflammation. Thus the investigators will study the effect of Vitamin D replacement in patients with Hepatitis C infection and Vitamin D deficiency.
Detailed description
Vitamin D appears to be a critical signaling molecule for macrophages because is needed for activation and differentiation of monocytes/macrophages. From our Preliminary Studies( VA Merit Review Grant), we propose that Vitamin D deficiency may alter the 'pro-inflammatory' ('classically activated') M1 macrophages , characterized by i\] high expression of NOS2, TNF-a, IL-1, IL-6, IL-8, TGF-a, CXCL10, and CCL19; and ii\] minimal expression of arginase 1 and mannose R. The clinical relevance of these findings is suggested by the presence of activated M1 macrophages in liver biopsies from patients with severe drug-induced liver injury (unpublished observations). Prospective vitamin D supplementation studies with appropriate endpoints are needed to define the role of vitamin D on inflammation in patients with chronic liver diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vitamin D | Vitamin D 500,000 IU given orally on Day 1 |
| DRUG | Placebo | Placebo given orally on Day 1 |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2013-10-01
- Completion
- 2014-01-01
- First posted
- 2012-12-21
- Last updated
- 2012-12-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01754961. Inclusion in this directory is not an endorsement.